Literature DB >> 4122362

A clinical review of bleomycin--a new antineoplastic agent.

R H Blum, S K Carter, K Agre.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4122362     DOI： 10.1002/1097-0142(197304)31:4<903::aid-cncr2820310422>3.0.co;2-n

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  104 in total

Review 1.  The role of antitumor antibiotics in current oncologic practice.

Authors:  H L Davis; D D von Hoff; J E Henney; M Rozencweig
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

2.  Pulmonary veno-occlusive disease after chemotherapy.

Authors:  B K Knight; A G Rose
Journal:  Thorax       Date:  1985-11       Impact factor: 9.139

3.  Prognostic impact of bleomycin pulmonary toxicity on the outcomes of patients with germ cell tumors.

Authors:  Yuki Maruyama; Takuya Sadahira; Yosuke Mitsui; Motoo Araki; Koichiro Wada; Ryuta Tanimoto; Yasuyuki Kobayashi; Masami Watanabe; Toyohiko Watanabe; Yasutomo Nasu
Journal:  Med Oncol       Date:  2018-04-26       Impact factor: 3.064

4.  Prevention of bleomycin-induced pulmonary fibrosis after adenovirus-mediated transfer of the bacterial bleomycin resistance gene.

Authors:  P L Tran; J Weinbach; P Opolon; G Linares-Cruz; J P Reynes; A Grégoire; E Kremer; H Durand; M Perricaudet
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

5.  Bleomycin lung: a case report.

Authors:  Rabia Sofia Rashid
Journal:  BMJ Case Rep       Date:  2009-04-14

6.  Catalytic mechanism of bleomycin N-acetyltransferase proposed on the basis of its crystal structure.

Authors:  Kosuke Oda; Yasuyuki Matoba; Masafumi Noda; Takanori Kumagai; Masanori Sugiyama
Journal:  J Biol Chem       Date:  2009-11-03       Impact factor: 5.157

7.  Bleomycin pharmacokinetics in man. II. Intracavitary administration.

Authors:  D S Alberts; H S Chen; M Mayersohn; D Perrier; T E Moon; J F Gross
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

8.  An A,B,C,D of cancer chemotherapy.

Authors:  E Y Chan; R J Cohen
Journal:  West J Med       Date:  1979-06

9.  Chemotherapy of thyroid carcinoma.

Authors:  S Ahuja; H Ernst
Journal:  J Endocrinol Invest       Date:  1987-06       Impact factor: 4.256

10.  Preliminary results of chemo-radiotherapy followed or not by active immunotherapy of stage III and IV lymphosarcoma and reticulosarcoma. Correlation of the results with WHO categorisation.

Authors:  J L Misset; G Mathé; M Tubiana; B Caillou; F de Vassal; P Pouillart; M Gil; C Tentas; M Hayat; L Schwarzenberg; C Jasmin; M Delgado; D Machover; P Ribaud; M Musset
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.